Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Accord Healthcare Announces Acquisition of Essential Pharmaceuticals

By Accord Healthcare | July 27, 2017

Accord Healthcare announced the acquisition of Ewing, NJ-based Essential Pharmaceuticals. Under the terms of the agreement, along with the Essential company, Accord has acquired the rights to sell Custodiol HTK Solution in the United States and Canada. Custodiol HTK Solution is a leading organ preservation solution indicated for perfusion and flushing of donor kidneys, liver, pancreas and heart prior to and after removal from donor.  

“We are thrilled to be expanding on our capabilities of providing life-saving, affordable medicines and therapies to patients and healthcare providers alike. Custodiol HTK is a vital product in the organ donation process and we are excited to include it in our product offering, as well as build upon the research and development programs in place for future organ preservation drug products,” said Gerald Price, president of Accord Healthcare.  

Commenting on the acquisition, Allan Weber, former CEO of Essential said: “As a growth oriented company, we couldn’t have found a better partner than Accord Healthcare. Valued Custodiol HTK customers can expect to see the same familiar faces of our transplant specialists, as well as experience the same outstanding customer service to which they have grown accustomed.”   

Accord Healthcare is the 12th largest generic pharmaceutical firm in the United States, per IMS Health.  The company’s U.S. headquarters is in Durham, NC. It is a part of the Intas Group, headquartered in Ahmedabad, India.

(Source: PR Newswire)

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards